This indicates that the PD-1/PD-L1 axis is not the important mediator of immune dysfunction in CLL as was previously assumed, and blockade of PD-1/PD-L1 interaction as a single agent does not induce clinical responses. The gene discussed is CD274; the disease is B-cell chronic lymphocytic leukemia.